{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-074450","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2023-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.887113+00:00","generated_at":"2026-06-13T17:06:25.868261+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"NextCure adopts amended bylaws, elects three directors, ratifies auditor at 2023 annual meeting","bullets":["Bylaws amended June 22, 2023 to incorporate Delaware law updates and universal proxy rule requirements.","Stockholders elected Class I directors Anne Borgman, John G. Houston, and Garry A. Nicholson.","Ratified Ernst & Young as independent auditor for fiscal year ending Dec 31, 2023 (19.67M for, 155k against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-074450","json":"https://secwatch.observer/filing/0001104659-23-074450.json","markdown":"https://secwatch.observer/filing/0001104659-23-074450.md","text":"https://secwatch.observer/filing/0001104659-23-074450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000110465923074450/0001104659-23-074450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000110465923074450/tm2319533d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:06:25.868261+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"efa79c0071868c9c39b4fa8b605cf2125a96ec81","claim":"NextCure, Inc.: Amended and restated bylaws to update adjournment procedures, stockholder meeting lists, director nomination rules, and universal proxy rules compliance (effective 2023-06-22).","evidence_excerpt":"On June 22, 2023, the board of directors (the “Board”) of NextCure, Inc. (the “Company”) approved and adopted the Second Amended and Restated Bylaws of the Company (the “A&R Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000110465923074450/0001104659-23-074450-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-06-22"}],"fact_type":"governance_change"},{"claim_id":"2d4f76664d33a6cd3668f5de0669653a645cf0a0","claim":"NextCure, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023 at the 2023-06-22 meeting.","evidence_excerpt":"On June 22, 2023, the Company held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders: (i) elected the three Class I members of the Board, each to serve for a three-year term expiring at the Company’s 2026 Annual Meeting of Stockholders and until such director’s earlier death, resignation, or removal from the Board; and (ii) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000110465923074450/0001104659-23-074450-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-22"}],"fact_type":"shareholder_vote"},{"claim_id":"3a380dd5e5dea3487516a3012be03e3ec5876563","claim":"NextCure, Inc. shareholders approved Election of Class I Directors at the 2023-06-22 meeting.","evidence_excerpt":"On June 22, 2023, the Company held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders: (i) elected the three Class I members of the Board, each to serve for a three-year term expiring at the Company’s 2026 Annual Meeting of Stockholders and until such director’s earlier death, resignation, or removal from the Board; and (ii) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000110465923074450/0001104659-23-074450-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-22"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}